In search of the cell biology for self- versus non-self- recognition
Sebastien Apcher1, Borek Vojtesek2, Robin Fahraeus3
1Institut Gustave Roussy, Université Paris Sud, UMR 1015, Villejuif, France.
Abstract:
Several of today's cancer treatments are based on the immune system's capacity to detect and destroy cells expressing neoantigens on major histocompatibility class-I molecules (MHC-I). Despite this, we still do not know the cell biology behind how antigenic peptide substrates (APSs) for the MHC-I pathway are produced. Indeed, there are few research fields with so many divergent views as the one concerning the source of APSs. This is quite remarkable considering their fundamental role in the immune systems' capacity to detect and destroy virus-infected or transformed cells. A better understanding of the processes generating APSs and how these are regulated will shed light on the evolution of self-recognition and provide new targets for therapeutic intervention. We discuss the search for the elusive source of MHC-I peptides and highlight the cell biology that is still missing to explain how they are synthesised and where they come from.
Insights
The source of antigenic peptide substrates (APSs) for cancer-targeting immune responses remains unknown. Understanding APS production is crucial for developing new cancer therapies and understanding immune self-recognition.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Cancer treatments leverage the immune system's ability to recognize neoantigens on major histocompatibility class-I (MHC-I) molecules.
- The cellular mechanisms producing antigenic peptide substrates (APSs) for the MHC-I pathway are poorly understood.
- This knowledge gap hinders the development of effective immunotherapies.
Purpose of the Study:
- To explore the unresolved question of APS origin for the MHC-I pathway.
- To highlight the missing cell biology in APS synthesis and sourcing.
- To identify potential new targets for therapeutic intervention.
Main Methods:
- Review and synthesis of existing research on peptide processing and presentation.
- Discussion of divergent views on the sources of APSs.
- Identification of critical knowledge gaps in cellular mechanisms.
Main Results:
- The precise cellular origin and synthesis pathways for APSs remain elusive.
- Significant debate exists regarding the sources of peptides presented by MHC-I.
- Current understanding lacks the cell biology to explain APS generation.
Conclusions:
- Elucidating APS production is fundamental for advancing cancer immunotherapy.
- Understanding APS sources will illuminate the evolution of self-recognition.
- Further research into the cell biology of APS synthesis is urgently needed.
More Related Videos
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Glycocalyx and its Functions


